摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(-)-[(5,6),(5',6')-双(乙烯二氧)联苯-2,2'-基]二苯基磷 | 503538-68-9

中文名称
(S)-(-)-[(5,6),(5',6')-双(乙烯二氧)联苯-2,2'-基]二苯基磷
中文别名
——
英文名称
(S)-synphos
英文别名
(S)-(-)-[(5,6),(5',6')-bis(ethylenedioxy)biphenyl-2,2'-diyl]bis(diphenylphosphine);[5-(6-diphenylphosphanyl-2,3-dihydro-1,4-benzodioxin-5-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]-diphenylphosphane
(S)-(-)-[(5,6),(5',6')-双(乙烯二氧)联苯-2,2'-基]二苯基磷化学式
CAS
503538-68-9
化学式
C40H32O4P2
mdl
——
分子量
638.639
InChiKey
GDMCOFXEPNHXJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >260 °C
  • 沸点:
    738.4±60.0 °C(Predicted)
  • 稳定性/保质期:

    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    8.4
  • 重原子数:
    46
  • 可旋转键数:
    7
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    36.9
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    29310099
  • 危险类别码:
    R36/37/38,R20/21/22
  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存放在4°C阴凉干燥处。

SDS

SDS:b85012a842a613b8665a8a2038933526
查看

Section 1: Product Identification
Chemical Name: S-(-)-6,6'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-5,5'-bi-1,4-benzodioxin, min. 97% (S)-SYNPHOS™
CAS Registry Number: 503538-68-9
Formula: C40H32O4P2
EINECS Number: none
Chemical Family: organophosphine ligand
Synonym: (S)-SYNPHOS,S-(-)--6,6'-Bis-diphenylphosphanyl-2,3,2',3'- tetrahydro-[5,5']bi[benzo[1,4]dioxinyl]

Section 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title compound 503538-68-9 100% no data no data

Section 3: Hazards Identification
Emergency Overview: Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure: Ingestion, inhalation, skin, eyes
Eye Contact: Causes mild irritation of the eyes.
Skin Contact: Causes mild irritation of the skin.
Inhalation: Inhalation of dust will lead to irritation of the respiratory tract.
Ingestion: No information available on the physiological effects of ingestion.
Acute Health Affects: Irritating to skin, eyes and respiratory tract.
Chronic Health Affects: No information on long-term chronic effects.
NTP: No
IARC: No
OSHA: No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point: no data
Autoignition Temperature: no data
Explosion Limits: no data
Extinguishing Medium: carbon dioxide, dry powder or foam
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion and If involved in a fire this material may emit toxic organic fumes and phosphorus pentoxide.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards

SECTION 6: Accidental Release Measures
Spill and Leak Procedures: Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Handling and Storage: Store in a tightly sealed container. Keep away from heat and direct sunlight.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear protective clothing and gloves.
Ventilation: Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation: Handle the material in an efficient fume hood.
Additional Protection: No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form: white powder
Molecular Weight: 638.63
Melting Point: no data
Boiling Point: no data
Vapor Pressure: no data
Specific Gravity: no data
Odor: none
Solubility in Water: insoluble

SECTION 10: Stability and Reactivity
Stability: air and moisture stable
Hazardous Polymerization: no hazardous polymerization
Conditions to Avoid: none
Incompatibility: strong oxidizing agents
Decomposition Products: carbon monoxide, carbon dioxide, phosphorus oxides and organic fumes.

SECTION 11: Toxicological Information
RTECS Data: No information available in the RTECS files.
Carcinogenic Effects: no data available
Mutagenic Effects: no data available
Tetratogenic Effects: no data available

SECTION 12: Ecological Information
Ecological Information: No information available

SECTION 13: Disposal Considerations
Disposal: Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR): Non-hazardous
Hazard Class (CFR): NA
Additional Hazard Class (CFR): NA
Packaging Group (CFR): NA
UN ID Number (CFR): NA
Shipping Name (IATA): Non-hazardous
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): NA

SECTION 15: Regulatory Information
TSCA: Not listed in the TSCA inventory
SARA (Title 313): Title compound not listed
Second Ingredient: none


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-(-)-[(5,6),(5',6')-双(乙烯二氧)联苯-2,2'-基]二苯基磷双氧水 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以96%的产率得到[(5,6),(5',6')-bis(ethylenedioxy)biphenyl-2,2'-diyl]bis(diphenylphosphine oxide)
    参考文献:
    名称:
    Cu(I)-催化吡咯与二芳基碘鎓盐不对称芳基化合成 N-N 阻转异构体
    摘要:
    我们在此报道,使用二氧化二膦配体的铜 (I) 催化可以催化前手性联吡咯的不对称 C-H 芳基化。以优异的产率和优异的对映选择性(≤97% 产率,≤98% ee)实现了 50 多种氮-氮阻转异构体。该反应在温和条件下进行,在芳烃和二芳基碘鎓盐上具有良好的官能团相容性。此外,该原理使得联吡咯的重复芳基化能够在铜催化过程中对映选择性芳基化不同的位置。
    DOI:
    10.1021/acs.orglett.2c00812
  • 作为产物:
    参考文献:
    名称:
    用于钌催化不对称氢化的新型高效二膦配体 SYNPHOS 的合成和分子建模研究
    摘要:
    一种新的光学活性阻转异构二膦配体,(2,3,2',3'-四氢-5,5'-bi(1,4-benzodioxin)-6,6'-diyl)bis-(diphenylphosphane) ( SYNPHOS®),已被合成、表征并用于钌催化的不对称氢化。这种新配体已与其他阻转异构二膦(BINAP 和 MeO-BIPHEP)在分子模型计算的二面角和钌介导的氢化反应的对映选择性方面进行了比较。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
    DOI:
    10.1002/ejoc.200200634
  • 作为试剂:
    描述:
    methyl 1-((2-acetoxyethoxy)methyl)-5-bromo-1H-1,2,4-triazole-3-carboxylate苯佐卡因(S)-(-)-[(5,6),(5',6')-双(乙烯二氧)联苯-2,2'-基]二苯基磷tris-(dibenzylideneacetone)dipalladium(0)potassium carbonate 作用下, 以 甲苯 为溶剂, 反应 16.0h, 以71%的产率得到Methyl 1-(2-acetyloxyethoxymethyl)-5-(4-ethoxycarbonylanilino)-1,2,4-triazole-3-carboxylate
    参考文献:
    名称:
    Ligand-Mediated Highly Effective and Selective C−N Coupling for Synthesizing BioactiveN-Aryltriazole Acyclonucleosides
    摘要:
    N-aryltriazole nucleosides are new chemical entities with potential biological activity. The two phosphor ligands, Synphos and Xantphos, had a selective and effective impact on Pd-catalyzed C-N coupling with the 5- and 3-bromotriazole acyclonucleoside isomers, affording the corresponding and otherwise difficult to achieve N-aryltriazole nucleosides with good to excellent yields. In addition, two of the synthesized nucleosides showed superior anticancer activity against drug-resistant pancreatic cancer, compared to the reference drug gemcitabine.
    DOI:
    10.1021/ol102537p
点击查看最新优质反应信息

文献信息

  • Chiral <i>cis</i>-Platinum Acetylide Complexes via Diphosphine Ligand Exchange: Effect of the Ligand
    作者:Amber L. Sadowy、Michael J. Ferguson、Robert McDonald、Rik R. Tykwinski
    DOI:10.1021/om800633h
    日期:2008.12.8
    Chiral, bidentate phosphine ligands (R,R-CHIRAPHOS, R-PROPHOS, S,S-BDPP, R,R-Me-DUPHOS, R,R-NORPHOS) react with trans-platinum acetylide complexes 1a and 1b, (Ph3P)2Pt(C≡CR)2 (R = TIPS, p-MeC6H4), via ligand exchange to generate chiral platinum acetylide complexes. The corresponding cis-platinum complexes are formed in all cases except for the reaction of 1b with S,S-BDPP, where the dimeric complex
    手性二齿膦配体(R,R -CHIRAPHOS,R- PROPHOS,S,S- BDPP,R,R- Me-DUPHOS,R,R- NORPHOS)与反乙炔化物络合物1a和1b(Ph 3 P)2 Pt(C≡CR)2(R = TIPS,p -MeC 6 H 4),通过配体交换产生手性的乙炔络合物。在所有情况下均形成相应的顺铂络合物,但1b与S,S- BDPP的反应除外,其中二聚体络合物4d'是产品。相反,1a和1b与配体S,S -DIOP,R -BINAP和R -SYNPHOS的反应未能以可观的收率得到所需的产物。圆二色光谱用于检查手性配体乙炔骨架的手性的影响。报道了非手性络合物1a和手性衍生物4e的X射线晶体学分析。
  • Benzimidazoles as Ligands in the Ruthenium-Catalyzed Enantioselective Bifunctional Hydrogenation of Ketones
    作者:Jeremy M. Praetorius、Ruiyao Wang、Cathleen M. Crudden
    DOI:10.1021/om900897b
    日期:2010.2.8
    ligands bound to the ruthenium center are active for the mild and chemoselective hydrogenation of ketones in the presence of alkenes. Catalysts that exist as a single diastereomer, prepared with enantiomerically pure diphosphanes, catalyze the hydrogenation of prochiral ketones with moderate levels of enantioselectivity that are significantly improved relative to catalysts existing in several conformations
    L = N的一系列Cl 2 Ru(diphosphane)L 2(II)配合物已经合成并表征了通过氮键与属键合的1-烷基化苯并咪唑。对于1-甲基苯并咪唑,所得络合物以所有可能的构象异构体的统计混合物形式存在。当苯并咪唑上的取代基的大小增加到10时,可以制备出以单一非对映异构体形式存在的络合物。所有具有结合到中心的苯并咪唑配体的配合物在烯烃存在下对酮的轻度和化学选择性氢化均具有活性。用对映体纯的二膦制备的以单一非对映异构体形式存在的催化剂以中等对映体选择性催化前手性酮的氢化,相对于以几种构象存在的催化剂,该手性酮的氢化显着提高。
  • Chiral C2-symmetric biphenyls, their preparation and also metal complexes in which these ligands are present and their use as catalysts in chirogenic syntheses
    申请人:Peschko Christian
    公开号:US20050250951A1
    公开(公告)日:2005-11-10
    A new class of C 2 -symmetric biaryldiphosphines comprising a fused ring system (dioxacycle) which has at least seven ring atoms and can be varied synthetically. The biaryldiphosphines can be used as ligands for preparing metal complexes useful as catalysts in organic synthesis, and the dioxacycles can be varied to optimize reaction with specific substrates.
    一种新型的C2对称的双芳基二膦化合物,包括至少七个环原子的融合环系统(二氧环),可以在合成过程中进行变化。这些双芳基二膦化合物可以用作配体,用于制备属配合物,这些属配合物在有机合成中作为催化剂,而二氧环可以进行变化以优化与特定底物的反应。
  • [EN] INTERMOLECULAR C-H SILYLATION OF UNACTIVATED ARENES<br/>[FR] SILYLATION C-H INTERMOLÉCULAIRE D'ARÈNES INACTIVÉS
    申请人:UNIV CALIFORNIA
    公开号:WO2015035325A1
    公开(公告)日:2015-03-12
    Reaction mixtures for silvlating arene substrates and methods of using such reaction mixtures to silyiate the arene substrates are provided. Exemplary reaction mixtures include the arene substrate, a liganded metal catalyst, a hydrogen acceptor and an organic solvent. The reaction conditions allow for diverse substituents on the arene substrate.
    提供了用于基化芳烃底物的反应混合物以及使用这种反应混合物来基化芳烃底物的方法。示例反应混合物包括芳烃底物、配体属催化剂、氢受体和有机溶剂。反应条件允许芳烃底物上具有多样的取代基。
  • Novel diphosphines, their complexes with transisition metals and their use in asymmetric synthesis
    申请人:——
    公开号:US20040260101A1
    公开(公告)日:2004-12-23
    The invention relates to novel diphosphines, in optically pure or racemic form, of formula (I): 1 in which: R 1 and R 2 are a (C 5 -C 7 )cycloalkyl group, an optionally substituted phenyl group or a 5-membered heteroaryl group; and A is (CH 2 —CH 2 ) or CF 2 . The invention further relates to the use of a compound of formula (I) as a ligand for the preparation of a metal complex useful as a chiral catalyst in asymmetric catalysis, and to the chiral metal catalysts comprising at least one ligand of formula (I).
    该发明涉及一种新型二膦化合物,其为光学纯或外消旋形式,化学式(I)如下: 其中: R1和R2为(C5-C7)环烷基,可选择取代的苯基或5-成员杂环烷基;以及 A为(CH2- )或CF2。 该发明还涉及将化合物的化学式(I)用作配体,用于制备属配合物,该属配合物在不对称催化中作为手性催化剂有用,并且包括至少一个化学式(I)的手性属催化剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫